Omori Y - Search Results

1

Salivary gland cancer organoids are valid for preclinical genotype-oriented medical precision trials.

Ishikawa T, Ogawa T, Shiihara M, Usubuchi H, Omori Y, Hirose K, Itoh T, Yoshida T, Nakanome A, Okoshi A, Higashi K, Ishii R, Rokugo M, Wakamori S, Okamura Y, Kinoshita K, Katori Y, Furukawa T. Ishikawa T, et al. Among authors: omori y. iScience. 2023 Apr 20;26(5):106695. doi: 10.1016/j.isci.2023.106695. eCollection 2023 May 19. iScience. 2023. PMID: 37207275 Free PMC article.

2

Intraductal papillary neoplasms of the bile duct consist of two distinct types specifically associated with clinicopathological features and molecular phenotypes.

Aoki Y, Mizuma M, Hata T, Aoki T, Omori Y, Ono Y, Mizukami Y, Unno M, Furukawa T. Aoki Y, et al. Among authors: omori y. J Pathol. 2020 May;251(1):38-48. doi: 10.1002/path.5398. Epub 2020 Mar 10. J Pathol. 2020. PMID: 32100878

3

How does intestinal-type intraductal papillary mucinous neoplasm emerge? CDX2 plays a critical role in the process of intestinal differentiation and progression.

Omori Y, Ono Y, Kobayashi T, Motoi F, Karasaki H, Mizukami Y, Makino N, Ueno Y, Unno M, Furukawa T. Omori Y, et al. Virchows Arch. 2020 Jul;477(1):21-31. doi: 10.1007/s00428-020-02806-8. Epub 2020 Apr 15. Virchows Arch. 2020. PMID: 32291497

4

Serum Anti-p53 Antibody Can Serve as a Predictive Marker for Histological Grade of Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Hata T, Mizuma M, Motoi F, Iseki M, Omori Y, Hayashi H, Nakagawa K, Morikawa T, Kamei T, Naitoh T, Furukawa T, Unno M. Hata T, et al. Among authors: omori y. Pancreas. 2020 Jul;49(6):768-773. doi: 10.1097/MPA.0000000000001570. Pancreas. 2020. PMID: 32541631

5

GNAS mutation detection in circulating cell-free DNA is a specific predictor for intraductal papillary mucinous neoplasms of the pancreas, especially for intestinal subtype.

Hata T, Mizuma M, Motoi F, Omori Y, Ishida M, Nakagawa K, Hayashi H, Morikawa T, Kamei T, Furukawa T, Unno M. Hata T, et al. Among authors: omori y. Sci Rep. 2020 Oct 20;10(1):17761. doi: 10.1038/s41598-020-74868-2. Sci Rep. 2020. PMID: 33082481 Free PMC article.

6

Development of a system combining comprehensive genotyping and organoid cultures for identifying and testing genotype-oriented personalised medicine for pancreatobiliary cancers.

Shiihara M, Ishikawa T, Saiki Y, Omori Y, Hirose K, Fukushige S, Ikari N, Higuchi R, Yamamoto M, Morikawa T, Nakagawa K, Hayashi H, Mizuma M, Ohtsuka H, Motoi F, Unno M, Okamura Y, Kinoshita K, Furukawa T. Shiihara M, et al. Among authors: omori y. Eur J Cancer. 2021 May;148:239-250. doi: 10.1016/j.ejca.2021.01.047. Epub 2021 Mar 19. Eur J Cancer. 2021. PMID: 33752134

7

Pathways for the development of multiple epithelial types of intraductal papillary mucinous neoplasm of the pancreas.

Kobayashi T, Omori Y, Ono Y, Karasaki H, Mizukami Y, Makino N, Motoi F, Unno M, Ueno Y, Furukawa T. Kobayashi T, et al. Among authors: omori y. J Gastroenterol. 2021 Jun;56(6):581-592. doi: 10.1007/s00535-021-01783-2. Epub 2021 Apr 1. J Gastroenterol. 2021. PMID: 33796937

8

Serine/Threonine Kinase 11 Plays a Canonical Role in Malignant Progression of KRAS -Mutant and GNAS -Wild-Type Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Omori Y, Ono Y, Morikawa T, Motoi F, Higuchi R, Yamamoto M, Hayakawa Y, Karasaki H, Mizukami Y, Unno M, Furukawa T. Omori Y, et al. Ann Surg. 2023 Feb 1;277(2):e384-e395. doi: 10.1097/SLA.0000000000004842. Epub 2023 Jan 10. Ann Surg. 2023. PMID: 33914475

9

Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scoring in Combination with CA19-9.

Ono M, Ono Y, Nakamura T, Tsuchikawa T, Kuraya T, Kuwabara S, Nakanishi Y, Asano T, Matsui A, Tanaka K, Ebihara Y, Kurashima Y, Noji T, Murakami S, Shichinohe T, Mitsuhashi T, Omori Y, Furukawa T, Taniue K, Suzuki M, Sugitani A, Karasaki H, Mizukami Y, Hirano S. Ono M, et al. Among authors: omori y. Ann Surg Oncol. 2022 Aug;29(8):5007-5019. doi: 10.1245/s10434-022-11630-0. Epub 2022 Apr 10. Ann Surg Oncol. 2022. PMID: 35399143

10

GATA6 and CK5 Stratify the Survival of Patients With Pancreatic Cancer Undergoing Neoadjuvant Chemotherapy.

Kokumai T, Omori Y, Ishida M, Ohtsuka H, Mizuma M, Nakagawa K, Maeda C, Ono Y, Mizukami Y, Miura S, Kume K, Masamune A, Morikawa T, Unno M, Furukawa T. Kokumai T, et al. Among authors: omori y. Mod Pathol. 2023 May;36(5):100102. doi: 10.1016/j.modpat.2023.100102. Epub 2023 Jan 14. Mod Pathol. 2023. PMID: 36788090

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

722 results

Search Page